Scholar Rock Holding Corp - Common Stock, par value $0.001 per share (SRRK)

CUSIP: 80706P103

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
-86,566
SEC-reported price per share
$48.32
Number of holders
32
Value change
-$4,326,641
Number of buys
20
Number of sells
10
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
119,752,556

Security key

80706P103

Report period

Q3 2026

Institutions

32

Top holders

10

Ownership snapshot

Top reported holders of SRRK - Scholar Rock Holding Corp - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
6/15
Latest evidence
30 Jun 2026
13F 13D/G 3/4/5 Lead comparable stake: 15% 9 rows are not safely comparable across share classes. 13D/G row: FMR LLC Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 15%.

6 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Comparable ownership Top 5
FMR LLC 15%
Invus Global Management, LLC 8%
Samsara BioCapital, L.P. 7.2%
WELLINGTON MANAGEMENT GROUP LLP 5.6%
PRICE T ROWE ASSOCIATES INC /MD/ 5.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F 13D/G
Company
15%
Reported 13D/G · 31 Dec 2024
$989,738,234
17,995,241 shares
— 30 Jun 2026
Invus Global Management, LLC
13D/G 3/4/5
Invus Public Equities, L.P. · 10%+ Owner
8%
Reported 13D/G · 30 Jun 2026
$526,625,715
9,575,013 shares
-$68,750,000 30 Jun 2026
Samsara BioCapital, L.P.
13D/G
Srinivas Akkaraju
7.2%
Reported 13D/G · 03 Oct 2025
$260,368,230
6,991,553 shares
$0 03 Oct 2025
WELLINGTON MANAGEMENT GROUP LLP
13F 13D/G
Company
5.6%
Reported 13D/G · 31 Dec 2025
$369,989,675
6,727,085 shares
— 30 Jun 2026
PRICE T ROWE ASSOCIATES INC /MD/
13F 13D/G
Company · T. Rowe Price Associates, Inc.
5.4%
Reported 13D/G · 31 Mar 2026
$373,717,000
6,794,837 shares
— 30 Jun 2026
Redmile Group, LLC
13D/G 13F
Company
3.6%
Reported 13D/G · 30 Jun 2026
$237,110,060
4,311,092 shares
-$261,554,095 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
32
Shares
132,093
Rows available
32
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
306
Q3 2026 holders
32
Holder diff
-274
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .